Norris Perne & French LLP Eli Lilly & CO Transaction History
Norris Perne & French LLP
- $1.25 Billion
- Q1 2025
A detailed history of Norris Perne & French LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Norris Perne & French LLP holds 466 shares of LLY stock, worth $348,106. This represents 0.03% of its overall portfolio holdings.
Number of Shares
466
Previous 446
4.48%
Holding current value
$348,106
Previous $344,000
11.63%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
4,383Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$75.7 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$71.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.2 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$25.7 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $710B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...